| Literature DB >> 35511867 |
Sebastiano Giallongo1,2, Daniela Řeháková1, Tommaso Biagini3, Oriana Lo Re1,4, Priyanka Raina5, Gabriela Lochmanová6, Zbyněk Zdráhal6,7, Igor Resnick4,8,9, Pille Pata10,11, Illar Pata10, Martin Mistrík12, João Pedro de Magalhães5, Tommaso Mazza4, Irena Koutná1,13, Manlio Vinciguerra1,4.
Abstract
DNA damage repair (DDR) is a safeguard for genome integrity maintenance. Increasing DDR efficiency could increase the yield of induced pluripotent stem cells (iPSC) upon reprogramming from somatic cells. The epigenetic mechanisms governing DDR during iPSC reprogramming are not completely understood. Our goal was to evaluate the splicing isoforms of histone variant macroH2A1, macroH2A1.1, and macroH2A1.2, as potential regulators of DDR during iPSC reprogramming. GFP-Trap one-step isolation of mtagGFP-macroH2A1.1 or mtagGFP-macroH2A1.2 fusion proteins from overexpressing human cell lines, followed by liquid chromatography-tandem mass spectrometry analysis, uncovered macroH2A1.1 exclusive interaction with Poly-ADP Ribose Polymerase 1 (PARP1) and X-ray cross-complementing protein 1 (XRCC1). MacroH2A1.1 overexpression in U2OS-GFP reporter cells enhanced specifically nonhomologous end joining (NHEJ) repair pathway, while macroH2A1.1 knock-out (KO) mice showed an impaired DDR capacity. The exclusive interaction of macroH2A1.1, but not macroH2A1.2, with PARP1/XRCC1, was confirmed in human umbilical vein endothelial cells (HUVEC) undergoing reprogramming into iPSC through episomal vectors. In HUVEC, macroH2A1.1 overexpression activated transcriptional programs that enhanced DDR and reprogramming. Consistently, macroH2A1.1 but not macroH2A1.2 overexpression improved iPSC reprogramming. We propose the macroH2A1 splicing isoform macroH2A1.1 as a promising epigenetic target to improve iPSC genome stability and therapeutic potential.Entities:
Keywords: DNA damage; cell reprogramming; induced pluripotent stem cells; macroH2A1.1
Mesh:
Substances:
Year: 2022 PMID: 35511867 PMCID: PMC9199840 DOI: 10.1093/stmcls/sxab004
Source DB: PubMed Journal: Stem Cells ISSN: 1066-5099 Impact factor: 5.845